This inventor holds 1 USPTO granted patent. Top assignee: Hoeschst Aktiengesellschaft. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovations of Peter Hamann
Introduction
Peter Hamann is a notable inventor based in Kelkheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his work on elaiophylin derivatives. His innovative approach has led to advancements in antibacterial and antiviral treatments.
Latest Patents
Peter Hamann holds a patent for elaiophylin derivatives, which are described as compounds with the potential for pharmaceutical applications. The patent details the specific formulas and substituents involved, highlighting the compounds' antibacterial and antiviral activity. This invention represents a significant step forward in the development of new therapeutic agents.
Career Highlights
Throughout his career, Peter Hamann has been associated with Höchst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work there has allowed him to focus on the development of innovative compounds that address critical health challenges.
Collaborations
Peter has collaborated with Gerhard Kretzschmar, a fellow researcher, to further explore the potential applications of his inventions. Their partnership has contributed to the advancement of research in the field of pharmaceuticals.
Conclusion
Peter Hamann's contributions to the field of pharmaceuticals through his innovative work on elaiophylin derivatives demonstrate his commitment to advancing medical science. His patent reflects the potential for new treatments that can combat bacterial and viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile